| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/29/2012 | EP2423232A1 Cocktail antibody for determining histological type of carcinoma, determination kit and determination method |
| 02/29/2012 | EP2423231A2 PRLR-specific antibody and uses thereof |
| 02/29/2012 | EP2423230A1 Binding member for GM-CSF receptor |
| 02/29/2012 | EP2423229A1 Binding member for GM-CSF receptor |
| 02/29/2012 | EP2423228A1 Antibody containing igg2 having amino acid mutation introduced therein |
| 02/29/2012 | EP2423227A1 Human antibodies to human delta like ligand 4 |
| 02/29/2012 | EP2423226A2 Antibody-based diagnostics and therapeutics |
| 02/29/2012 | EP2423225A2 NOGO-A binding molecules and pharmaceutical use thereof |
| 02/29/2012 | EP2423218A1 Tag peptide having protease recognition sequence and utilization of same |
| 02/29/2012 | EP2422812A1 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 02/29/2012 | EP2422811A2 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 02/29/2012 | EP2421900A1 Monoclonal antibodies against pcbp-1 antigens, and uses therefor |
| 02/29/2012 | EP2421899A1 Anti-human ror1 antibodies |
| 02/29/2012 | EP2421898A1 Antibodies specific to cadherin-17 |
| 02/29/2012 | EP2421897A1 FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATES |
| 02/29/2012 | EP2421896A1 Antibody fusion proteins with modified fcrn binding sites |
| 02/29/2012 | EP2421888A1 A novel cell and therapeutical and diagnostical methods based thereon |
| 02/29/2012 | EP2421611A1 Fgfr1c antibody combinations |
| 02/29/2012 | EP2421559A2 Anti-tgf-beta induction of bone cell function and bone growth |
| 02/29/2012 | EP2421546A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality |
| 02/29/2012 | EP2421529A2 Siderophore conjugate immunogenic compositions and vaccines |
| 02/29/2012 | EP2421357A1 Animal models and therapeutic molecules |
| 02/29/2012 | EP2340850A9 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 02/29/2012 | EP2099913B1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 02/29/2012 | EP1949109B1 Peptide sequence that promotes tumor invasion |
| 02/29/2012 | EP1670826B1 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 02/29/2012 | EP1662007B9 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 02/29/2012 | EP1343875B1 Sugar beet genes involved in stress tolerance |
| 02/29/2012 | CN1972713B Pharmaceutical composition for treating or preventing cardiac dysfunction |
| 02/29/2012 | CN102365297A Novel anti-alpha5beta1 antibodies and uses thereof |
| 02/29/2012 | CN102365296A Methods for producing mixtures of antibodies |
| 02/29/2012 | CN102365097A Antibodies to clostridium difficile toxins |
| 02/29/2012 | CN102363771A Method for preparing alkaline phosphatase by monoclonal antibody technology |
| 02/29/2012 | CN102363768A Soybean lipoxygenase isozyme resisting monoclonal antibody hybridoma cell lines, and antibody and application thereof |
| 02/29/2012 | CN102363634A Method for preparing pyrethroid pesticide polyclonal antibody |
| 02/29/2012 | CN101570575B Sncg monoclonal antibody and application thereof |
| 02/29/2012 | CN101328211B Candidates outer membrane proteins of two leptospira vaccine |
| 02/28/2012 | US8124789 Method for producing glycosylated indole compound and antibody against the compound |
| 02/28/2012 | US8124750 Recombinant protective protein from Streptococcus pneumoniae |
| 02/28/2012 | US8124743 Purification of a bivalently active antibody using a non-chromatographic method |
| 02/28/2012 | US8124742 for isolation of DNA encoding anti-Rh(D) antibodies; isolation of DNA encoding antibodies directed against any red blood cells antigen or other cell antigen; for typing platelets by generating phage antibodies specific for a number of clinically important platelet antigens |
| 02/28/2012 | US8124741 Antibodies to tumor associated proteins |
| 02/28/2012 | US8124740 Anti- α5 β1 antibodies and uses thereof |
| 02/28/2012 | US8124739 Antibody to human Zcyto10 polypeptide |
| 02/28/2012 | US8124738 Human monoclonal antibodies to CD70 |
| 02/28/2012 | US8124732 Composition comprising isolated human CTLA4-Fc fusion protein produced in a transgenic chicken |
| 02/28/2012 | US8124731 Optimized Fc variants and methods for their generation |
| 02/28/2012 | US8124728 CA125 gene and its use for diagnostic and therapeutic interventions |
| 02/28/2012 | US8124725 PDGF-Rβ binders |
| 02/28/2012 | US8124380 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 02/28/2012 | US8124378 Murine zcytor17 ligand polynucleotides |
| 02/28/2012 | US8124373 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 02/28/2012 | US8124364 Extraction toxin from mammals body fluid; complexing with biotin |
| 02/28/2012 | US8124352 Methods and compositions for targeting HEPSIN |
| 02/28/2012 | US8124105 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 02/28/2012 | US8124099 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 02/28/2012 | US8124098 Polypeptides from non-typeable Haemophilus influenzae |
| 02/28/2012 | US8124092 Antibodies against H5N1 strains of influenza A virus |
| 02/28/2012 | US8124090 Anti-factor D antibodies and methods of treatment |
| 02/28/2012 | US8124086 Antibodies that bind cell-associated CA 125/O772P and methods of use thereof |
| 02/28/2012 | US8124085 Bispecific binding agents for modulating biological activity |
| 02/28/2012 | US8124084 Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15Ra |
| 02/28/2012 | US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders |
| 02/28/2012 | US8124080 Human monoclonal antibody having fat-reducing effect |
| 02/28/2012 | US8124079 Anti-IGF-IR antibodies and uses thereof |
| 02/28/2012 | US8124078 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 02/28/2012 | US8124077 Anti-IL-TIF antibodies and methods of making |
| 02/28/2012 | US8124076 Single chain antibodies against β-amyloid peptide |
| 02/28/2012 | US8124066 Methods of using interleukin-2 mutants with reduced toxicity |
| 02/28/2012 | CA2402240C A method for in vitro molecular evolution of antibody function |
| 02/28/2012 | CA2219361C Human antibodies derived from immunized xenomice |
| 02/23/2012 | WO2012024659A2 Antibody-based constructs directed against tyrosine kinase receptors |
| 02/23/2012 | WO2012024650A2 Anti-ngf antibodies and their use |
| 02/23/2012 | WO2012024242A1 Antibodies that bind myostatin, compositions and methods |
| 02/23/2012 | WO2012024223A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
| 02/23/2012 | WO2012024187A1 Amyloid-beta binding proteins |
| 02/23/2012 | WO2012023614A1 Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded |
| 02/23/2012 | WO2012023486A1 Antifreeze protein |
| 02/23/2012 | WO2012022985A1 Combined use of fc gamma riib (cd32b) and cd20 - specific antibodies |
| 02/23/2012 | WO2012022982A2 Improved antibodies of the class igg4 |
| 02/23/2012 | WO2012022814A1 Antibodies for epidermal growth factor receptor 3 (her3) |
| 02/23/2012 | WO2012022747A1 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody |
| 02/23/2012 | WO2012022734A2 Anti-icam-1 antibodies and methods of use |
| 02/23/2012 | WO2012022703A2 Improved anti-serum albumin binding variants |
| 02/23/2012 | WO2012022682A1 Anti-human igg1 antibody |
| 02/23/2012 | WO2012022290A2 Energy store cladding, and operating method |
| 02/23/2012 | WO2012021934A1 Humanized anti-interleukin 3 receptor alpha chain antibodies |
| 02/23/2012 | WO2012001179A3 Linear ige peptide epitopes of hazelnut allergen cor a 1 and celery antigen api 1 |
| 02/23/2012 | WO2011130644A3 Phosphorylated nf45 biomarkers, antibodies and methods of using same |
| 02/23/2012 | WO2011126576A3 Genetic signatures in the envelope glycoprotein of hiv-1 |
| 02/23/2012 | WO2011088288A3 Hybridoma cell lines and monoclonal antibodies recognizing anthrose saccharide of bacillus anthracis |
| 02/23/2012 | WO2003008563A3 Improved cytochrome p450 oxygenases |
| 02/23/2012 | US20120047586 Polypeptide having enhanced effector function |
| 02/23/2012 | US20120046458 Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 02/23/2012 | US20120046456 Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 02/23/2012 | US20120046452 Antibody-mediated rejection inhibitor |
| 02/23/2012 | US20120046451 ANTI-lgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 02/23/2012 | US20120046450 Modulation Of Antibody Effector Function By Hinge Domain Engineering |
| 02/23/2012 | US20120046448 Chlamydomonas intraflagellar transport 88 (ift-88) |
| 02/23/2012 | US20120046190 Hp1alpha as a prognostic marker in human cancer |